Litcius/Paper detail

Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017–2019

Hélio S. Sader, Jennifer M Streit, Rodrigo E. Mendes

2020Diagnostic Microbiology and Infectious Disease16 citationsDOI

Topics & Concepts

DalbavancinStreptococcus anginosusMicrobiologyEnterococcus faecalisStaphylococcus aureusBroth microdilutionEnterococcusVancomycinBiologyStreptococcaceaeStreptococcusAntibioticsBacteriaMinimum inhibitory concentrationGeneticsAntimicrobial Resistance in StaphylococcusBacterial Identification and Susceptibility TestingAntibiotic Resistance in Bacteria
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017–2019 | Litcius